[HTML][HTML] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - Springer
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
[HTML][HTML] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - ncbi.nlm.nih.gov
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
[HTML][HTML] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - ccforum.biomedcentral.com
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
[引用][C] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - espace.library.uq.edu.au
Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - go.gale.com
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
[引用][C] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman… - Critical care (London …, 2016 - pubmed.ncbi.nlm.nih.gov
Antibiotic dosing in obesity: a BIG challenge Antibiotic dosing in obesity: a BIG challenge Crit
Care. 2016 Aug 10;20(1):240. doi: 10.1186/s13054-016-1426-y. Authors Timothy P Hanrahan …
Care. 2016 Aug 10;20(1):240. doi: 10.1186/s13054-016-1426-y. Authors Timothy P Hanrahan …
[PDF][PDF] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - 2016 - cyberleninka.org
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
Antibiotic dosing in obesity: a BIG challenge.
TP Hanrahan, J Lipman, JA Roberts - Critical Care (London …, 2016 - europepmc.org
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …
[引用][C] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - Critical Care, 2016 - infona.pl
Antibiotic dosing in obesity: a BIG challenge × Close The Infona portal uses cookies, ie strings
of text saved by a browser on the user's device. The portal can access those files and use them …
of text saved by a browser on the user's device. The portal can access those files and use them …
[PDF][PDF] Antibiotic dosing in obesity: a BIG challenge
TP Hanrahan, J Lipman, JA Roberts - 2016 - core.ac.uk
When almost 60% of the world's population is predicted to be overweight by 2030 [1], dosing
regimens that are developed and tested in non-obese patients will be inappropriate for the …
regimens that are developed and tested in non-obese patients will be inappropriate for the …